Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
Products, services, technology
Drawing on 17 years in the biotechnology industry lending expertise across both early and late stages of development in therapeutic areas including immune-mediated and neurological disorders; infectious diseases; CV & metabolism; orphan indications including pediatric/adult neurological disorders.
Cooperation possibilities
Exploratory clinical drug/diagnostic development requires cross-functional input across a number of functions including but not limited to Biostatistics, Clinical Operations, Bioinformatics, Commercial Pipeline and is tailored to the need of the program.